2Firsts Successfully Hosts NGP+AI Workshop, Launches Global Call for Outstanding AI Application Cases

May.08
On April 15, 2025, 2Firsts held its first “NGP+AI” workshop in Shenzhen, focusing on real-world AI applications in the NGP industry—from formula digitization to automated flavor development and compliance tools. The event gathered professionals across R&D and tech roles. 2Firsts also launched a global call for outstanding NGP+AI use cases, offering media exposure, resource access, and innovation support to accelerate the industry’s intelligent transformation.

 

Reported by 2Firsts from Shenzhen — On April 15, 2025, 2Firsts, a global media and think tank platform dedicated to the next-generation product (NGP) industry, successfully held its first “NGP+AI” workshop in Shenzhen, themed “AI 101 for NGP Professionals.” The workshop focused on the innovative applications of artificial intelligence in the NGP sector and attracted key participants from leading domestic manufacturers, brand owners, and service providers in R&D, technology, and compliance.

 

As AI continues to reshape global industry structures, the NGP sector stands at the dawn of a new transformation. Through this workshop, 2Firsts initiated an in-depth discussion on how AI can empower product development, regulatory compliance, supply chain optimization, and market responsiveness—offering a roadmap toward intelligent and data-driven industry evolution.

 

2Firsts Successfully Hosts NGP+AI Workshop, Launches Global Call for Outstanding AI Application Cases
Photo: Workshop in session

 

The session was delivered by AI applications expert Jiaxian Ren from SMART DOG, who introduced the fundamentals of large language models and their practical implementation in areas such as formula digitization, automated flavor development, label recognition, and regulatory analysis. The workshop emphasized the shift “from experience-driven to data-driven,” helping professionals grasp the potential and boundaries of integrating AI with industrial processes.

 

2Firsts Successfully Hosts NGP+AI Workshop, Launches Global Call for Outstanding AI Application Cases
Jiaxian Ren explaining AI applications in the NGP industry

 

2Firsts emphasized that AI is not merely an additional tool in the NGP industry, but a force for systematic and foundational change. In a global environment where regulation is tightening and innovation is accelerating, AI is poised to become a critical driver in enhancing corporate resilience, improving R&D efficiency, and strengthening compliance systems.

 

The workshop also featured a live demonstration of an AI-powered flavor development device, presented by an innovation team from Shenzhen. The system showcased how AI can contribute to flavor identification and formula optimization, completing a closed loop from data to product. The demonstration sparked strong interest and lively discussion among attendees.

 

2Firsts Successfully Hosts NGP+AI Workshop, Launches Global Call for Outstanding AI Application Cases
Live demo of the AI-assisted flavor blending device

 

“This was not just a workshop—it was a glimpse into the future of our industry,” said Alan Zhao, Co-Founder and CEO of 2Firsts. “Through continued exploration and practice, we aim to provide a window and a pathway for AI-driven transformation in the global NGP sector and contribute to the high-quality development of tobacco harm reduction worldwide.”

 

2Firsts Successfully Hosts NGP+AI Workshop, Launches Global Call for Outstanding AI Application Cases
2Firsts CEO Alan Zhao moderating the workshop

 

To further promote AI-NGP integration, 2Firsts has officially launched a Global NGP+AI Application Case Call. Selected cases will receive support ranging from media exposure and business matchmaking to IP consultation and investor connections. For early-stage startups, 2Firsts will offer free resources to support innovation and implementation.

 

NGP professionals, researchers, and entrepreneurs worldwide are welcome to submit their cases or concepts related to AI applications in the NGP sector. Please contact us at: info@2firsts.com

2Firsts Interviews ASDF on Malaysia’s Vape Ad Ban, Total Prohibition Plans, and What’s Next
2Firsts Interviews ASDF on Malaysia’s Vape Ad Ban, Total Prohibition Plans, and What’s Next
Malaysia’s Vape Market in Turmoil.Since the implementation of Act 852, Malaysia’s e-cigarette sector has been undergoing intense upheaval. From stricter compliance inspections and a full advertising ban to a proposal for a complete sales prohibition, a regulatory storm is reshaping the industry landscape.2Firsts talks with leading local brand ASDF to learn how it is responding to challenges and laying out a compliance roadmap in the current policy environment.
Aug.14
Asia Pacific Harm Reduction Alliance Criticizes Singapore’s Policy: Confusing Illegal “Drug Pods” with Legal E-Cigarettes May Fuel Black Market Circulation
Asia Pacific Harm Reduction Alliance Criticizes Singapore’s Policy: Confusing Illegal “Drug Pods” with Legal E-Cigarettes May Fuel Black Market Circulation
The Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA) has expressed concern over Singapore Prime Minister Lawrence Wong’s recent announcement to treat e-cigarettes as a “drug issue” and impose imprisonment penalties. CAPHRA stated that this policy confuses illegal products containing etomidate with legal nicotine devices, goes against harm reduction science, deprives adult smokers of access to safer alternatives, and may instead fuel black market circulation.
Aug.19 by 2FIRSTS.ai
BAT's H1 2025 Financial Report: Vuse Sales Down Nearly 13%, Velo Revenue up Over 40%
BAT's H1 2025 Financial Report: Vuse Sales Down Nearly 13%, Velo Revenue up Over 40%
BAT reported H1 2025 revenue of £12.07 billion, down 2.2% due to FX, but up 1.8% at constant rates. Smoke-free products made up 18.2% of total revenue, with Velo sales rising 40.6%. BAT maintained its full-year outlook and raised its 2025 share buyback to £1.1 billion.
Jul.31 by 2FIRSTS.ai
Singapore to Classify Etomidate as Class C Drug from September; Importers and Sellers Face Up to 20 Years in Prison
Singapore to Classify Etomidate as Class C Drug from September; Importers and Sellers Face Up to 20 Years in Prison
Singapore will classify the anesthetic etomidate as a Class C drug from September 1, with traffickers and users facing prosecution and a minimum one-year jail term. The move comes amid growing concerns over the health risks posed by etomidate-laced e-cigarettes, which have become increasingly popular. The government has stepped up enforcement efforts, seizing over 850 e-cigarettes in recent operations.
Aug.25 by 2FIRSTS.ai
PMI Launches ZYN Nicotine Pouches in Guatemala, Marking First Entry in Central America
PMI Launches ZYN Nicotine Pouches in Guatemala, Marking First Entry in Central America
Philip Morris International (PMI) has launched ZYN nicotine pouches in Guatemala, offering a lower-risk alternative to smoking and accelerating progress toward a smoke-free future. Developed by a Swedish company, the product reduces the emission of harmful chemicals and is targeted at adult smokers.
Jul.07 by 2FIRSTS.ai
Scotland E-Cigarette Market Report (2): Elfbar, Lost Mary, and SKE See Significant Declines, Gold Bar Plunges 93.5%; Pixl and Higo Strongly Grow
Scotland E-Cigarette Market Report (2): Elfbar, Lost Mary, and SKE See Significant Declines, Gold Bar Plunges 93.5%; Pixl and Higo Strongly Grow
Talysis data reveals a "brand reshuffling" in Scotland post-ban. Leading brands like Elf Bar, Lost Mary, and SKE dropped sharply, while emerging brands Pixl and Higo surged. Compliant alternatives like blu and Hyola performed well.
Aug.06 by 2FIRSTS.ai